Mediterranean and low-histamine diets for teen hives
Part of Immune system & allergy, Skin clinical trials.
This study tests whether following a Mediterranean diet or a low-histamine diet can help reduce symptoms of chronic spontaneous urticaria (hives) in teens. It compares the two diets to see which one might work better for managing this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 18 years old.
- You must have a confirmed diagnosis of chronic spontaneous urticaria (hives that last more than 6 weeks).
- You cannot have used certain strong medications (like systemic corticosteroids, biologics, or immunosuppressants) recently.
- You must have no other chronic diseases, neurodevelopmental disorders, or food allergies.
- You must not be on a special therapeutic diet or have an acute infection.
- Both you and a parent/legal guardian must agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medicine for chronic hives (called chronic spontaneous urticaria). It is for people whose hives still bother them about once or twice a month despite daily treatment, and who do not have heart problems.
This study tests whether avoiding certain foods and food additives can reduce chronic hives (itchy welts on skin) in children and teenagers. Researchers will have participants follow a special diet and track their symptoms over time.
This study looks at how diet and oxidative stress (a type of cell damage) affect the severity of chronic hives and how well patients respond to the medication omalizumab (Xolair). It may help find ways to improve treatment by understanding these factors.
This study tests an investigational pill called THB335 for adults whose hives (itchy welts) keep appearing despite taking antihistamines. The goal is to see if this treatment can reduce itching and hives and improve quality of life.
This study tests a new medication called HRS-3095 to see if it can help people whose chronic hives (itchy welts) do not get better with standard allergy pills. It aims to reduce itching and wheals and improve quality of life.
This study tests a low-dose immune therapy (interleukin-2) for people with chronic hives that don't get better with standard allergy pills. If you are an adult with ongoing hives and itching despite daily antihistamines, this trial might offer a new treatment option.
Hear when a new Urticaria Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.